Phone: (212) 746-5788
Fax: (212) 746-0975
March 25, 2010 5:01 am
Data from OncoGenex Pharmaceuticals' Product Candidate OGX-427 to be Presented ... - PR Newswire (pr
Google News - bladder cancer
Data from OncoGenex Pharmaceuticals' Product Candidate OGX-427 to be Presented ... PR Newswire (press release) The study, which will enroll up to 36 patients with bladder cancer, is designed to determine the safety and potential benefit of OGX-427 administered ... |
|